%20.png)
OUR MISSION
is to Design and Develop Advanced Endovascular Devices for Optimal Extraction of Thrombus from the vascular system
60,000-100,000 Americans die of DVT/PE
0 to 30% of people will die within one month of diagnosis
Sudden death is the first symptom in about one-quarter (25%) of people who have a PE
our device technology
A Novel Thrombectomy System
Vascular Medcure has developed a novel thrombectomy system for the non-surgical removal of soft emboli and thrombi from peripheral blood vessels, PE1, and thrombosed AV Graft1. The CAPERE® Thrombectomy System features a mechanical retrieval method with no need for thrombolytic drugs, aspiration or capital equipment. The system allows complete retrieval of soft emboli and thrombi while providing distal and proximal protection.
1 PE & AV Graft Device not available for sale
our leaders
Executive Management Team
Samuel Shaolian
CEO
Duy Nguyen
Co-Founder & VP
Thanh Nguyen
Co-Founder & VP
Contact Us
We Want to Hear from You
Tel: 657-549-5175
Fax: 714-399-0168
Address:
1500 South Sunkist Street, Suite H, Anaheim, CA 92806
%20.png)
The CAPERE® Thrombectomy System is protected by US Patents No. 9,579116, 9,636,206, 9,744,024, 9,844,386, 9,999,493, 10,070879, 10,143,482, 10,238,482, 10,376,275 and other pending patent applications. CAPERE® is a registered trademark of Vascular Medcure, Inc.